Amlodipine Besylate And Benazepril Hydrochloride Capsule
Product Images NDC 70518-2566

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate And Benazepril Hydrochloride (NDC 70518-2566). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

55323c6b 4efc 466a 82ff 7a5d66b77c2d 01

HCI stands for Human-Computer Interaction. It refers to the study of the design and use of computer technology by humans. HCI focuses on the communication between humans and computers, as well as the design of interfaces and technologies to make this interaction more seamless and effective. The goal of HCI is to create user-friendly interfaces and systems that are intuitive and easy to use for people with varying levels of digital literacy.*

FDA Label Image

55323c6b 4efc 466a 82ff 7a5d66b77c2d 02

FDA Label Image

Remedy_label (Remedy Label)

amLODIPine/Benazepril HCI is a type of medication that comes in a capsule form with 10mg/20 mg strength. The quantity of the capsule is 90, and the NDC # is 70518-2666-00. The source NDC is 68180-0472-01, and it has been manufactured by Lupin Pharma located in Maryland. It is advised to store the capsule at a temperature range of 20-26°C (63-77°F) with excursions permitted at 15-30°C (59-86°F) [See USP]. Users should check the package insert for direction on how to use the medication. The medication was repackaged by RemedyRepack Inc., Indiana, PA 15701, and it should be kept out of children’s reach.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.